Dr Nancy Sacco is currently the VP and Head of Clinical Development at AnaptysBio, Inc, with 20+ years of experience through all phases of Clinical Development. She has worked with numerous CROs, clinical vendors and clinical investigator sites around the globe and is focused on best practices and optimizing operations toward highest quality deliverables and data. Prior to AnaptysBio, Dr Sacco led Clinical Operations globally at Revance, Avexis and Takeda, overseeing clinical trials across aesthetics, neuromuscular and psychiatric disorders, metabolic disease, women’s health, infectious diseases/immunology, oncology, and gene therapy/rare disease. She was Executive Director of Strategic Operations at Astellas Pharmaceutics Global Development with responsibilities across US, Europe and Japan. While at P&G, Warner Lambert/Pfizer, she had operational and leadership roles with increasing responsibilities. Over her career she has contributed to the development of Zolgensma, Xtandi, Myrbetriq, Cresemba, Lyrica, Rozerem and Risedronate. Beyond drug product development, Dr Sacco represented Astellas on both the Transcelerate and AVOCA consortia where she contributed to the development of Risk-based monitoring, GCP Global Recognition for clinical investigators and Clinical Quality Management initiatives. https://www.linkedin.com/in/nancy-sacco-888738b/
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948